Indication

Pseudomonas aeruginosa meningitis

*Pseudomonas aeruginosa* meningitis is an uncommon but severe central nervous system infection defined by bacterial inflammation of the leptomeninges surrounding the brain and spinal cord. Read more about Pseudomonas aeruginosa meningitis

28 drugs 21 manufacturers

Advertisement

Drugs that treat it

Common Pseudomonas aeruginosa meningitis therapies.

Showing 19–27 of 28 drugs

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Hikma Pharmaceuticals USA

GENTAMICIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
EUGIA US LLC

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
Avet Pharmaceuticals

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
AVET-NOVAPLUS

GENTAMICIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
Hikma Pharmaceuticals USA

AMIKACIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·STAPHYLOCOCCAL SEPTICEMIA·+60
FRESENIUS KABI

GENTAMICIN SULFATE

AMINOGLYCOSIDES, PARENTERAL·SEPSIS CAUSED BY ENTEROBACTER·+63
FRESENIUS KABI
Filter & compare in the drug finder →Opens the drug finder with Pseudomonas aeruginosa meningitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Pseudomonas aeruginosa meningitis.

*Pseudomonas aeruginosa* meningitis is an uncommon but severe central nervous system infection defined by bacterial inflammation of the leptomeninges surrounding the brain and spinal cord.

It most frequently arises as a healthcare-associated or opportunistic complication in individuals undergoing invasive neurosurgical procedures, spinal anesthesia, or external ventricular drain placement, as well as in patients with penetrating head trauma or significant immunocompromise.

Pathophysiologically, the opportunistic Gram-negative bacillus gains access to the subarachnoid space via direct inoculation, local anatomical breach, or less commonly hematogenous seeding, provoking profound cerebrospinal fluid inflammation, high intracranial pressures, and microvascular thrombosis that carry substantial risks of neurological sequelae and mortality.

Personalize your experience

Follow Pseudomonas aeruginosa meningitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it